Mercado de dispositivos de cirurgia microinvasiva do glaucoma (MIGS) Ásia-Pacífico – Tendências do setor e previsão para 2029

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado de dispositivos de cirurgia microinvasiva do glaucoma (MIGS) Ásia-Pacífico – Tendências do setor e previsão para 2029

  • Medical Devices
  • Publish Reports
  • Aug 2022
  • Asia-Pacific
  • 350 Páginas
  • Número de tabelas: 80
  • Número de figuras: 39

>Mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS) da Ásia-Pacífico, por produto (stents MIGS, shunts MIGS e outros), alvo (malha trabecular, filtração subconjuntival do espaço supracoroidal e redução da produção aquosa), tipo de cirurgia (glaucoma em conjunto com catarata e stand- Apenas Glaucoma ), Utilizador Final (Departamentos Hospitalares de Ambulatório (HOPD), Clínicas Oftalmológicas, Centros de Cirurgia Ambulatória (ASCS) e Outros), Canal de Distribuição (Concurso Directo e Vendas a Retalho) - Tendências do Sector e Previsão para 2029.  

Mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS)

Análise e dimensão do mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS) da Ásia-Pacífico

A cirurgia microinvasiva do glaucoma é utilizada para tratar o glaucoma de ângulo aberto. Inicialmente, para tratar o OAG, foram administrados medicamentos que reduziam a produção de humor aquoso ou aumentavam o fluxo de humor aquoso. Para a OAG ligeira a moderada, tradicionalmente, era realizado tratamento farmacológico e laser. Com o advento dos procedimentos de cirurgia microinvasiva do glaucoma (MIGS), foram criadas novas opções para aqueles que não estão aptos para a cirurgia convencional. Espera-se que o aumento da população de geriatria e o aumento das iniciativas governamentais para a prevenção da cegueira impulsionem o mercado. A rápida transição da medicação para o glaucoma para cirurgias de glaucoma minimamente invasivas pode estar a criar oportunidades para o fabricante de dispositivos MIGS. No entanto, as fracas facilidades de reembolso podem constituir um obstáculo para o mercado.

Mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS)

Mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS)

O aumento da procura de cirurgia microinvasiva deve-se à crescente incidência de doenças oculares, ao aumento da procura de cirurgias microinvasivas e à redução do trauma cirúrgico, impulsionando a necessidade do mercado no período de previsão. No entanto, o elevado custo de instalação e a escassez de profissionais qualificados podem dificultar o crescimento do mercado da cirurgia minimamente invasiva no período de previsão.

A Data Bridge Market Research analisa que o mercado de dispositivos para cirurgia microinvasiva de glaucoma (MIGS) deverá atingir o valor de 787,04 milhões de dólares até 2029, com um CAGR de 30,6% durante o período de previsão. A “MIGS Stents” é responsável pelo maior segmento de tecnologia no mercado de dispositivos de cirurgia microinvasiva do glaucoma (MIGS) devido aos rápidos desenvolvimentos nos caminhos tecnológicos para comercializar a utilização de dispositivos de cirurgia microinvasiva do glaucoma (MIGS). dispositivos também cobre em profundidade os avanços tecnológicos.         

Métrica de relatório

Detalhes

Período de previsão

2022 a 2029

Ano base

2021

Anos históricos

2020 (personalizável para 2019 - 2014)

Unidades Quantitativas

Receita em milhões de dólares

Segmentos cobertos

Por produto (derivação MIGS, stent MIGS e outros), alvo (malha trabecular, espaço supracoroidal, filtração subconjuntival e redução da produção aquosa), cirurgia (glaucoma em conjunto com catarata, glaucoma autónomo), utilizador final (hospital, oftalmologia Clínicas, Centros Cirúrgicos Ambulatório (ASCS) e Outros), Canal de Distribuição (Concurso Directo e Venda a Retalho)

Países abrangidos

China, Coreia do Sul, Japão, Índia, Austrália, Singapura, Malásia, Indonésia, Tailândia, Filipinas, Resto da Ásia-Pacífico na Ásia-Pacífico

Participantes do mercado abrangidos

AbbVie, BVI, Ellex, Glaukos Corporation, Johnson and Johnson, Alcon, tecnologia microcirúrgica, New World Medical, Santen Pharmaceutical, Nova Eye Medical Limited, Belkin Vision e Sight Scientific, entre outros.

Definição de mercado

MIGS significa cirurgia microinvasiva do glaucoma, que ajuda a tratar o glaucoma. É uma tecnologia inovadora no tratamento do glaucoma ligeiro a moderado. É uma alternativa aos medicamentos administrados anteriormente e previne também as complicações da cirurgia convencional. Estes procedimentos são utilizados para diminuir a pressão intraocular do olho para evitar danos no nervo ótico. Estes procedimentos são mais seguros e têm um tempo de recuperação muito rápido, em comparação com a cirurgia convencional. Os vários dispositivos MIGS implantados são shunts e stents para diminuir a PIO.

Dinâmica do mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS)

  • Aumento da população geriátrica

Um problema significativo relacionado com a saúde entre os idosos é a perda de visão. De acordo com a Academia Americana de Médicos de Família, aos 65 anos, uma em cada três pessoas sofre de doenças oculares que reduzem a visão. A população idosa está a aumentar rapidamente. Portanto, isto cria uma procura por tecnologias avançadas para tratar o glaucoma entre os adultos mais velhos. Portanto, o aumento da população geriátrica é um impulsionador do mercado.

  • Aumento da incidência de glaucoma em todo o mundo

A causa da cegueira global irreversível é principalmente o glaucoma. O glaucoma é um grupo de doenças oculares que apresentam poucos ou nenhuns sintomas na fase inicial, mas que posteriormente levam a danos nos nervos óticos, o que pode levar à perda de visão ou cegueira. A prevalência do glaucoma tem vindo a aumentar. Portanto, isto cria uma procura por dispositivos MIGS; assim, espera-se que uma incidência crescente de glaucoma atue como um impulsionador do mercado.

  • Iniciativas governamentais para aumentar a consciencialização sobre a prevenção da cegueira

Segundo a OMS, pelo menos 2,2 mil milhões de pessoas têm deficiência visual e cegueira, das quais pelo menos mil milhões têm uma deficiência visual que poderia ter sido evitada. Para os evitar, os governos de vários países de todo o mundo tomaram iniciativas. Isto cria uma procura por tratamentos avançados, como a cirurgia microinvasiva do glaucoma, o que impulsiona o mercado de dispositivos MIGS. Portanto, espera-se que atue como um impulsionador do mercado.

  • Introdução de produto tecnológico avançado 

Glaucoma is a severe eye disease that can lead to vision loss if not controlled. It generally does not lead to blindness as it can be controlled by modern treatment and many options for preventing further damage. With the increased scientific developments, there has been a revolutionary change in the treatment of glaucoma. With the advent of micro-invasive glaucoma surgery, there is a paradigm shift in medicine as it can help in the treatment of glaucoma at an early stage and avoid the dependency on filtration surgeries like trabeculectomy. This also overcomes the risks associated with these incisional surgeries. There are various advancements in the treatment of glaucoma with MIGS.

Restraints/Challenges faced by the Market

  • Stringent regulations for MIGS devices

There are at least 7 regulations that any device manufacturer must completely fulfill in the U.S., namely Establishment Registration & Medical Device Listing, Premarket Notification 510(k), Premarket Approval (PMA)(only for class three devices), Investigational Device Exemption (IDE) for clinical studies, Quality System (QS) regulation, Labeling requirements, and Medical Device Reporting (MDR). These highest-risk devices need a more stringent premarket application regulatory process to demonstrate valid evidence of safety and efficacy. Lengthy timelines result in delayed access, which might restrict the market for MIGS devices.

  • High cost of surgical procedures

Though glaucoma treatments have modest results and are safer than traditional filtration surgeries, they have very high costs. Also, people may require subsequent surgeries if the intra-ocular pressure is not effectively lowered at once. All these considerations make these procedures highly costly and inaccessible to most people and hence, high surgical procedure costs might be a restraint on the market.

Recent Developments

  • In January 2022, Glaukos announced GLK=301's first patient enrolment in the Phase II clinical trial for dry eye disease. After the successful approval from the regulatory body, this drug will help the company grow its business segment.
  • In January 2022, Alcon acquired Ivantis, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device. This surgical device is designed to lower eye pressure for open-angle glaucoma patients. This acquisition will enhance the company’s portfolio in eye surgery segment.

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope

The micro invasive glaucoma surgery (MIGS) devices market is segmented on the basis of product, target, surgery, end user, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • MIGS stents
  • MIGS shunts
  • Others

On the basis of product, the micro invasive glaucoma surgery (MIGS) devices market is segmented into MIGS shunts, MIGS stents, and others.

Target

  • Trabecular meshwork
  • Suprachoroidal space
  • Subconjunctival filtration
  • Reducing aqueous production

On the basis of target, the micro invasive glaucoma surgery (MIGS) devices market is segmented into the trabecular meshwork, suprachoroidal space, subconjunctival filtration, and reducing aqueous production.

Surgery

  • Glaucoma in conjunction with cataract
  • Stand-alone glaucoma

On the basis of surgery, the micro invasive glaucoma surgery (MIGS) devices market is segmented into glaucoma in conjunction with cataract and stand-alone glaucoma.

End User

On the basis of end-user, the micro invasive glaucoma surgery (MIGS) devices market is segmented into hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS), and others.

Distribution Channel

  • Direct tender
  • Retail sales

Mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS)

On the basis of distribution channel, the micro invasive glaucoma surgery (MIGS) devices market is segmented into direct tender and retail sales.

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Regional Analysis/Insights

The micro invasive glaucoma surgery (MIGS) devices market is analysed and market size insights and trends are provided by country, product, target, surgery, end user, and distribution channel as referenced above.

The countries covered in the micro invasive glaucoma surgery (MIGS) devices market report are China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and Rest of Asia-Pacific.  

China dominates the Asia-Pacific micro invasive glaucoma surgery (MIGS) devices market. The demand in this region is projected to be driven by market players who are focusing on expanding their regional product offerings and enhancing their presence in emerging markets through various growth strategies, such as, expansions, partnerships, and collaborations among others.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share Analysis

O panorama competitivo do mercado de dispositivos de cirurgia microinvasiva do glaucoma (MIGS) fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença regional, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas no mercado de dispositivos para cirurgia microinvasiva do glaucoma (MIGS).

Alguns dos principais players que operam no mercado de dispositivos de cirurgia microinvasiva do glaucoma (MIGS) são a AbbVie, BVI, Ellex, Glaukos Corporation, Johnson and Johnson, Alcon, tecnologia microcirúrgica, New World Medical, Santen Pharmaceutical, Nova Eye Medical Limited, Belkin Vision e Sight Scientific, entre outros.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INTERNATIONAL STANDARDS

4.2 REGIONAL STANDARDS

4.3 MARKET VIEWPOINT OF KEY OPINION LEADERS

4.4 EXPECTATIONS OF FUTURE MARKET SCENARIOS

4.5 FINDINGS AND REGIONAL TRENDS

4.6 COMPETITIVE GROUPING

5 COUNTRY WISE- NO OF PROCEDURES

5.1 NORTH AMERICA

5.2 EUROPE

5.3 ASIA-PACIFIC

5.4 SOUTH AMERICA

5.5 MIDDLE EAST AND AFRICA

6 REGULATION

6.1 UNITED STATES

6.2 EUROPE

6.3 CHINA

6.4 AUSTRALIA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASE IN THE GERIATRIC POPULATION

7.1.2 RISE IN INCIDENCE OF GLAUCOMA ACROSS THE WORLD

7.1.3 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT THE PREVENTION OF BLINDNESS

7.1.4 GROWTH IN POPULARITY OF MINIMALLY INVASIVE SURGERY ACROSS THE GLOBE

7.2 RESTRAINTS

7.2.1 INADEQUATE REIMBURSEMENT SCENARIO

7.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES

7.2.3 HIGH COST OF SURGICAL PROCEDURES

7.3 OPPORTUNITIES

7.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES

7.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT

7.4 CHALLENGES

7.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE

7.4.2 RISKS ASSOCIATED WITH THE MICRO INVASIVE GLAUCOMA SURGERY

8 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 MIGS STENTS

8.3 MIGS SHUNTS

8.4 OTHERS

9 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET

9.1 OVERVIEW

9.2 TRABECULAR MESHWORK

9.3 SUPRACHOROIDAL SPACE

9.4 SUBCONJUNCTIVAL FILTRATION

9.5 REDUCING AQUEOUS PRODUCTION

10 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE

10.1 OVERVIEW

10.2 GLAUCOMA IN CONJUNCTION WITH CATARACT

10.3 STAND-ALONE GLAUCOMA

11 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITAL

11.3 OPHTHALMOLOGY CLINICS

11.4 AMBULATORY SURGERY CENTERS (ASCS)

11.5 OTHERS

12 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

13 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION

13.1 ASIA-PACIFIC

13.1.1 CHINA

13.1.2 JAPAN

13.1.3 INDIA

13.1.4 SOUTH KOREA

13.1.5 AUSTRALIA

13.1.6 SINGAPORE

13.1.7 THAILAND

13.1.8 MALAYSIA

13.1.9 INDONESIA

13.1.10 PHILIPPINES

13.1.11 REST OF ASIA-PACIFIC

14 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 GLAUKOS CORPORATION

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.4.1 RECENT DEVELOPMENT

16.2 ALCON INC.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.4.1 RECENT DEVELOPMENTS

16.3 ABBVIE INC.

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.4.1 RECENT DEVELOPMENT

16.4 JOHNSON & JOHNSON SURGICAL VISION, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON)

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.4.1 RECENT DEVELOPMENT

16.5 SANTEN PHARMACEUTICAL CO., LTD.

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.4.1 RECENT DEVELOPMENTS

16.6 BELKIN VISION, ISRAEL

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 BVI

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.2.1 RECENT DEVELOPMENTS

16.8 ELLEX INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.2.1 RECENT DEVELOPMENTS

16.9 IOPTIMA

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 MICROSURGICAL TECHNOLOGY. (A SUBSIDIARY OF HALMA PLC)

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.2.1 RECENT DEVELOPMENT

16.11 NEW WORLD MEDICAL, INC.

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.2.1 RECENT DEVELOPMENTS

16.12 NOVA EYE MEDICAL LIMITED

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.3.1 RECENT DEVELOPMENTS

16.13 SIGHT SCIENCES.

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.3.1 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Lista de Tabela

TABLE 1 NUMBER OF PEOPLE (AGED 40-80 YEARS, IN MILLIONS) WITH GLAUCOMA IN 2013 AND PROJECTION OF THE NUMBER OF PEOPLE HAVING GLAUCOMA IN 2020 AND 2040

TABLE 2 NEW OPTIONS FOR GLAUCOMA TREATMENT

TABLE 3 NUMBER OF PHYSICIANS/ THOUSAND POPULATIONS

TABLE 4 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 5 ASIA PACIFIC MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 ASIA PACIFIC MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 ASIA PACIFIC OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 9 ASIA PACIFIC TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 ASIA PACIFIC SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 ASIA PACIFIC SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 ASIA PACIFIC REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 14 ASIA PACIFIC GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 ASIA PACIFIC STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 17 ASIA PACIFIC HOSPITAL IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 ASIA PACIFIC OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 ASIA PACIFIC AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 ASIA PACIFIC OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 22 ASIA PACIFIC DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 ASIA PACIFIC RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 25 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 26 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 27 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 28 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 29 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 30 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 31 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 32 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 33 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 34 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 35 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 36 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 37 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 38 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 39 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 40 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 41 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 42 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 43 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 44 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 45 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 46 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 47 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 48 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 50 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 51 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 52 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 53 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 54 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 55 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 56 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 57 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 58 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 59 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 60 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 61 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 62 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 63 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 64 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 65 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 66 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 67 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 68 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 69 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 70 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 71 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 72 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 73 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 74 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 75 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 76 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 77 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 78 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 79 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 80 REST OF ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

Lista de Figura

FIGURE 1 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID

FIGURE 9 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 PRODUCT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLAUCOMA SURGERY (MIGS) DEVICES MARKET

FIGURE 14 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2021

FIGURE 15 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)

FIGURE 16 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 17 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2021

FIGURE 19 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022-2029 (USD MILLION)

FIGURE 20 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2022-2029)

FIGURE 21 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE

FIGURE 22 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2021

FIGURE 23 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022-2029 (USD MILLION)

FIGURE 24 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2022-2029)

FIGURE 25 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 26 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2021

FIGURE 27 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 28 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 29 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 31 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 32 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 33 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)

FIGURE 35 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)

FIGURE 36 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 37 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)

FIGURE 39 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market value is expected USD 787.04 million by 2029.
The Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market is to grow at a CAGR of 30.6% during the forecast by 2029.
The major players operating in the Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market are AbbVie, BVI, Ellex, Glaukos Corporation, Johnson and Johnson, Alcon, Microsurgical technology, New World Medical, Santen Pharmaceutical, Nova Eye Medical Limited, Belkin Vision, and Sight Scientific among others.
The major countries covered in the Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market are China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific in Asia-Pacific.